$SOTK

Sono-Tek (NASDAQ: SOTK) awards VP Kuha 7,205 stock options

Sono-Tek (SOTK) granted VP Maria T. Kuha 7,205 stock options with an exercise price of $5.35 per share. The options vest on 2027-08-20 and expire on 2036-08-20, exercisable into common shares. Kuha now holds 35,001 options directly.

Original reporting
Published Aug 24, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$SOTK
Neutral
high confidence
Mentioned
$SOTK
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$SOTKNeutralLow
01

Why it matters

The award is a routine compensation event with limited market relevance.

02

Market read

Low relevance; the disclosed option grant is small and does not provide a clear trading opportunity.

03

What to watch

Potential future dilution if many options are exercised, but current impact is negligible.

Relevance 4/10Novelty 2/10Timing: 2026-08-20 filing date

Background

Sono‑Tek Corp (NASDAQ:SOTK) filed a Form 4 reporting an insider option grant to its Vice President.

Company-level read

Ticker impact

$SOTKNeutralHigh confidence
Context

SEC Form 4 disclosed VP Maria T. Kuha received a grant of 7,205 stock options at $5.35 exercise price on 2026-08-20.

Expected impact

Minimal impact; no immediate trading signal.

Evidence & confidence

The grant value is about $39K, well below material thresholds for price movement.

Market effects

None; the option grant does not affect the broader equipment sector.

None; limited to Sono‑Tek shareholders.

None

Counterpoint

If the insider plans to exercise options later, it could signal confidence, but the small size makes this unlikely.

Key entities

  • Maria T. Kuha

    Vice President of Sono‑Tek receiving the option grant.

Related articles

$SOTKMed

Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales

$SOTKMed

Sono-Tek stock rises on record $3.6M production line order

Sono-Tek Corp (NASDAQ:SOTK) shares rose 3.9% premarket after the company said it received a $3.6 million order for an integrated advanced manufacturing production line for medical diagnostic device coating. Sono-Tek said it is its largest single-line order, placed by an existing customer moving to high-volume manufacturing, with shipment expected in fiscal 2028.

$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

$SOTKMed

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.